Company Filing History:
Years Active: 1989-1998
Title: Syed Hamiduddin Hasan: Innovator in Pharmaceutical Science
Introduction
Syed Hamiduddin Hasan is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical science, particularly in the development of agents for gynecological and reproductive health. With a total of 2 patents, his work has the potential to impact both human and animal health.
Latest Patents
One of his latest patents is focused on the combined use of an antigestagen and a progesterone synthesis inhibitor. This pharmaceutical agent contains a progesterone synthesis inhibitor of the trilostane or epostane type and an antigestagen. It can be utilized for inducing delivery at term in humans and animals, for terminating normal or pathological pregnancies, and for treating hormone-dependent tumors, endometriosis, or dysmenorrhea. Another significant patent involves the coadministration of antigestagen and antiestrogen for gynecological purposes. This agent contains at least one compound with antiprogestational activity and at least one compound with anti-estrogenic activity. It is suitable for inducing labor, terminating pregnancy, and treating various gynecological disorders.
Career Highlights
Syed Hamiduddin Hasan is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative solutions in reproductive health.
Collaborations
Throughout his career, he has collaborated with notable colleagues such as Walter Elger and Sybille Beier. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Syed Hamiduddin Hasan is a distinguished inventor whose work in pharmaceutical science has the potential to improve health outcomes in gynecology and reproductive medicine. His innovative patents reflect his commitment to advancing medical science and addressing critical health issues.